Advertisement
Screener

NOVAVAX INC (NVAX) Pre-Tax Margin

NOVAVAX INC (NVAX) Pre-Tax Margin

  • 2026-06-30: Pre-Tax Margin -91.14%.
  • 2026-03-31: Pre-Tax Margin -6.10%.
  • 2025-12-31: Pre-Tax Margin 12.17%.
  • 2025-09-30: Pre-Tax Margin -288.22%.

Complete source-backed pre-tax margin history.

Available history
2010-12-31 to 2026-06-30
Data captured

Historical Pre-Tax Margin

DatePre-Tax Margin
2026-06-30-91.14%
2026-03-31-6.10%
2025-12-3112.17%
2025-09-30-288.22%
2025-06-3044.91%
2025-03-3177.98%
2024-12-31-83.32%
2024-09-30-144.75%
2024-06-3039.61%
2024-03-31-154.80%
2023-12-31-60.65%
2023-09-30-70.31%
2023-06-3013.63%
2023-03-31-361.60%
2022-12-31-51.63%
2022-09-30-22.62%
2022-06-30-273.80%
2022-03-3129.27%
2021-12-31-373.39%
2021-09-30-176.91%
2021-06-30-117.03%
2021-03-31-49.13%
2020-12-31-63.49%
2020-09-30-125.66%
2020-06-30-49.30%
2014-12-31-469.16%
2014-09-30-240.16%
2014-06-30-216.30%
2014-03-31-185.07%
2013-12-31-160.62%
2013-09-30-318.62%
2013-06-30-357.63%
2013-03-31-260.34%
2012-12-31-175.97%
2012-09-30-125.19%
2012-06-30-83.35%
2012-03-31-158.04%
2011-12-31-63.39%
2011-09-30-64.14%

Annual Pre-Tax Margin

DatePre-Tax Margin
2025-12-3139.36%
2024-12-31-25.89%
2023-12-31-55.20%
2022-12-31-32.98%
2021-12-31-149.57%
2020-12-31-87.94%
2019-12-31-711.04%
2015-12-31-432.93%
2014-12-31-270.55%
2013-12-31-248.42%
2012-12-31-129.13%
2011-12-31-129.03%
2010-12-31-10541.69%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Immunocore Holdings plc (IMCR)$1.613B-90.43
Taysha Gene Therapies, Inc. (TSHA)United States$1.564B-14.80
Vericel Corp (VCEL)United States$2.011B93.97
Inhibrx Biosciences, Inc. (INBX)United States$1.477B-10.08
Maze Therapeutics, Inc. (MAZE)United States$1.457B-12.40
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16